PASG earnings: a unknown outcome, -20.3%

On January 12, 2026, Passage BIO, Inc. reached its earnings. The result was a unknown outcome, and the stock moved -20.3% in the window around the event. It had already run +141.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.